ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Results 31 - 40 of 58
Presenter(s): Danielle M Connor, MS, CCC-SLP; Annie Govea, MS, CCC-SLP
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: As a result of the COVID-19 pandemic, access to our patients for in-person treatment may be limited and our ability to develop a relationship with patients/caregivers may have taken a toll due to facility protocols to protect against the spread of infection. As health care providers, we must reflect on our abilities to communicate with patients and their families, ensuring understanding of their deficits and treatment options even as we continue through a pandemic. This course provides the clinician with a review of holistic assessments and health literacy approaches that will empower the patient to make informed decisions. This course is a recorded session from the 2021 ASHA Convention Virtual Library (session 2140V).
Presenter(s): Stephen Camarata, PhD, CCC-SLP; Benjamin Hornsby, PhD, CCC-A; Fred Bess, PhD; Hilary Davis, AuD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Recent studies have implicated fatigue as an important consequence of listening effort, but the impact of fatigue on children is poorly understood. One problem is the lack of a measure of listening-related fatigue. In this presentation, the presenters (1) introduce the construct of listening-related fatigue, and (2) describe the development and validation of the Vanderbilt Fatigue Scale designed to quantify listening-related fatigue. This course was presented and recorded at the 2019 ASHA Convention.
Presenter(s): Mary Beth Lannon, EdD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This recorded session from the ASHA Audiology 2022 Online Conference explores access to audiological services for individuals with intellectual disabilities. The speaker discusses testing adaptions, as well as training for students and professionals, that can maximize outcomes for these individuals. The session highlights the Special Olympics Healthy Athletes program as an example of a service that is successfully improving audiological evaluation and outcomes for individuals with intellectual disabilities.
Presenter(s): Sarah Ailey, PhD, RN, PHNA-BC, CNE, CDDN, FAAN; Megan A Morris, PhD, MPH, CCC-SLP; Carole Schwartz, MS, OTR/L
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session discusses a project that established a cross-sector national consortium of self-advocates with intellectual and developmental disabilities (IDD), family advocates, community providers, and health care professionals. The consortium guides and evaluates an environmental scan and literature review on best practices in educating health care professional students in the care of persons with IDD, including health care professional students addressing communication disorders.
Presenter(s): Pamela E Souza, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: According to recent research, an individual's success with using a hearing aid is connected to their cognitive ability. This course reviews the evidence and explains how to apply it to clinical decision-making to improve outcomes for each individual patient.
Presenter(s): Barbara E Weinstein, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This course explores the intricate connections between hearing loss and dementia, focusing on the process of screening patients with hearing loss for dementia and the impact of hearing assistance technology on the hearing status and communication function in patients with dementia.
Presenter(s): Carrie Nieman, MD, MPH
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Many older adults experience a growing number of comorbidities and functional limitations as they age. An individual’s ability and willingness to access hearing care is influenced not only by the severity of his or her hearing loss but also by other health, socioeconomic, and environmental factors. This session discusses recent research on patient outcomes as well as reviews lessons learned from a human factors approach to hearing care for older adults, including addressing common comorbid conditions.
Presenter(s): Mark A. Parker, PhD, CCC-A, F-AAA
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The audiogram is a poor representation of a person's underlying otopathology and can therefore be a poor predictor of a person's hearing impairment. For example, persons with audiometric thresholds within normal limits may experience hearing impairment such as difficulty hearing in noise. Cochlear synaptopathy and outer hair cell dysfunction are two otopathologies undetected by the standard audiogram (a.k.a. Hidden Hearing Loss), but outer hair cell function plays a primary role in hearing in noise performance. A third undetected otopathology is cochlear untuning, which occurs secondary to outer hair cell damage. This course discusses each of these otopathologies and presents clinical normative data that can be used to differentially diagnose each otopathology.
Presenter(s): Nicole L Marrone, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session provides practical information on implementing and expanding aural/audiologic rehabilitation programs for adults with hearing loss and their communication partners. The presenter discusses and provides examples of components of successful aural rehabilitation services, including assessment, communication training, technologies, and group counseling.
Presenter(s): Victoria A Sanchez, AuD, PhD, CCC-A, F-AAA; Ann Clock Eddins, PhD, MBA, CCC-A, FAAA
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Emerging treatment approaches for age-related hearing loss include alternative interventions aimed at ameliorating symptoms and slowing down or even preventing hearing loss, in contrast with current treatment approaches, which focus primarily on amplification and communication strategies. This session will explore up-and-coming approaches, such as pre-clinical investigation of hormones (e.g., Aldosterone) correlated with auditory function; medicinal-related interventions; and challenges to timelines to bring new treatments to market.
<< 1 2 3 4 5 6 >>